
HilleVax, Inc. (NASDAQ: HLVX) related to its sale to XOMA Royalty Corporation. Under the terms of the proposed transaction, HilleVax stockholders will receive $1.95 in cash per share, plus one non-transferable contingent value right, representing the right to receive additional payments under certain post-closing financial conditions.